Coya Therapeutics Inc. logo

Coya Therapeutics Inc.

COYA | NASDAQ
Chart Builder DCF Calculator
$5.23
+$0.28 (+5.66%)
Sep 22, 2026, 10:18 AM ET · Market open
Fiscal Quarter
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Revenue
243.75K 251.15K 3.96M 3.56M 163.62K 257.88K 1.95K n/a 3.43M 126.84K 6M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a 6.84K 6.84K 5.21M 1.94M 2.22M 4.57M 3.14M 1.61M 1.59M 1.07M 1.23M 4.41M n/a n/a n/a n/a n/a n/a n/a
Gross Profit
243.75K 251.15K 3.96M 3.56M 156.78K -4.96M -1.94M -2.22M -1.14M -3.01M 4.39M -1.59M -1.07M -1.23M -4.41M n/a n/a n/a n/a n/a n/a n/a
Operating Income
-7.05M -7.64M -6.03M -1.92M -6.41M -7.68M -4.08M -4.45M -3.24M -5.48M 1.82M -3.56M -3.25M -2.9M -2M -2.66M -3.45M -1.7M -1.6M -1.33M -970.49K -970.5K
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-6.64M -7.21M -5.71M -2.12M -6.09M -7.31M -3.64M -4.02M -2.89M -5.05M 1.99M -3.42M -3.1M -2.74M -3.11M -4.02M -3.41M -1.7M -1.63M -1.33M -966.07K -966.07K
Net Income
-6.64M -7.21M -5.71M -2.12M -6.09M -7.31M -2.92M -4.02M -2.89M -5.05M 1.27M -3.42M -3.1M -2.74M -3.11M -4.02M -3.41M -1.7M -1.63M -1.33M -966.07K -966.07K
Selling & General & Admin
2.26M 3.78M 3.27M 2.56M 2.91B 2.71M 2.14M 2.22M 2.09M 2.44M 2.38M 1.96M 1.83M 1.66M 898.65K 1.24M 1.99M 717.52K 732.15K 543.29K 518.3K 518.3K
Research & Development
5.03M 4.11M 6.71M 2.92M 3.66B 5.21M 1.94M 2.22M 4.57M 3.16M 1.8M 1.59M 1.42M 1.23M 1.1M 1.41M 1.45M 978.8K 855.81K 785.36K 450.48K 450.48K
Other Expenses
4.46K 2.81K 6.84K n/a -6.56B -5.21M -1.93M -2.22M -4.56M -3.13M -1.6M -1.59M -1.06M -1.22M -4.41M 12.46K 4.03K 4.03K 10.19K 2.53K 1.71K 1.71K
Operating Expenses
7.29M 7.89M 9.99M 5.47M 6.57M 2.72M 2.14M 2.23M 2.1M 2.47M 2.58M 1.97M 2.19M 1.67M -2.41M 2.66M 3.45M 1.7M 1.6M 1.33M 970.49K 970.5K
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
7.29M 7.89M 9.99M 5.48M 6.58M 7.93M 4.08M 4.45M 6.66M 5.61M 4.19M 3.56M 3.25M 2.9M 2M 2.66M 3.45M 1.7M 1.6M 1.33M 970.49K 970.5K
Income Tax Expense
n/a n/a 3.09K n/a n/a n/a -720.29K n/a n/a n/a 723.85K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
23.46M 22.64M 16.73M 16.73M 16.72M 16.72M 16.36M 15.22M 14.92M 14.46M 10.16M 9.95M 9.95M 9.95M 9.95M 9.68M 6.6M 6.6M 6.6M 9.68M 2.59M 2.59M
Shares Outstanding (Diluted)
23.46M 22.64M 16.73M 16.73M 16.72M 16.72M 16.36M 15.22M 14.92M 14.46M 10.16M 9.95M 9.95M 9.95M 9.95M 9.68M 6.6M 6.6M 6.6M 9.68M 2.59M 2.59M
EPS (Basic)
-0.28 -0.32 -0.34 -0.13 -0.36 -0.44 -0.18 -0.26 -0.19 -0.35 0.12 -0.34 -0.31 -0.26 -0.42 -0.42 -0.52 -0.26 -0.25 -0.14 -0.37 -0.37
EPS (Diluted)
-0.28 -0.32 -0.34 -0.13 -0.36 -0.44 -0.18 -0.26 -0.19 -0.35 0.12 -0.34 -0.31 -0.26 -0.42 -0.42 -0.52 -0.26 -0.25 -0.14 -0.37 -0.37
EBITDA
-6.64M -7.63M -5.7M -2.11M -6.09M -7.3M -3.63M -4.01M -2.88M -5.45M 2.02M -3.42M -2.9M -2.73M -1.61M -2.51M -3.41M -1.7M -1.62M -1.33M -964.36K -968.79K
EBIT
-6.64M -7.63M -5.71M -2.12M -6.09M -7.31M -3.64M -4.02M -2.89M -5.46M 2.01M -3.42M -2.9M -2.74M -1.61M -2.53M -3.41M -1.7M -1.63M -1.33M -966.07K -970.5K
Depreciation & Amortization
2.81K 2.81K 6.84K 6.84K 6.84K 6.84K 6.84K 6.84K 6.84K 6.84K 6.84K 6.84K 6.84K 6.84K 6.84K 12.46K 4.03K 4.03K 10.19K 2.53K 1.71K 1.71K

© 2026 bestshares.com. All rights reserved.